die(' Site is under construction

Dear site users

Site is under construction.

The site will be ready in less than 24 hours.

We are sorry for the inconvenience.

www.yektaweb.com

'); Reports of Biochemistry and Molecular Biology rbmb.net Basic Sciences http://rbmb.net 1 admin 2322-3480 2322-3480 10.61882/rbmb en jalali 1393 2 1 gregorian 2014 5 1 2 2 online 1 fulltext
en Inherited Genetic Markers for Thrombophilia in Northeastern Iran (a Clinical-Based Report) زیست شناسی ملکولی Molecular Biology <p style="text-align: justify;"><strong><em>Background:</em></strong> Thrombophilia is a main predisposition to thrombosis due to a procoagulant state. Several point mutations play key roles in blood-clotting disorders, which are grouped under the term thrombophilia. These thrombophilic mutations are methylenetetrahydrofolate reductase (MTHFR, C677T, and A1298C), factor V Leiden (G1691A), prothrombin gene mutation (factor II, G20210A), and plasminogen activator inhibitor (PAI). In the present study, we assessed the prevalence of the above thrombophilia markers in patients with recurrent pregnancy loss or first and second trimester abortions, infertility, and failed in vitro fertilization (IVF).</p> <p style="text-align: justify;"><em><strong>Methods:</strong></em> This study was conducted among 457 cases those were referred to detect the inherited genetic markers for thrombophilia. Markers for MTHFR, Factor II, and Factor V were assessed by polymerase chain reaction restriction fragment length polymorphism (PCR-RFLP), and PAI was assessed by Amplification Refractory Mutation System (ARMS-PCR).</p> <p style="text-align: justify;"><em><strong>Results:</strong></em> Two hundred sixty cases (56.89%) were diagnosed as having at least one thrombophilia marker, whereas 197 cases (43.11%) had no thrombophilia markers and were normal.</p> <p style="text-align: justify;"><em><strong>Conclusion:</strong></em> According to the current study, the pattern of abnormal genetic markers for thrombophilia in northeastern Iran demonstrates the importance of genetic evaluations in patients who show clinical abnormalities with recurrent spontaneous abortion (RSA) or other serious obstetric complications.</p> Factor II, Factor V, Thrombophilia, MTHFR, PAI, Thrombophilic markers 76 81 http://rbmb.net/browse.php?a_code=A-10-1-25&slc_lang=en&sid=1 Fatemeh Keify 10031947532846005986 10031947532846005986 No Pardis Clinical and Genetics Laboratory, Mashhad, Iran. Mohsen Azimi-Nezhad 10031947532846005987 10031947532846005987 No Pardis Clinical and Genetics Laboratory, Mashhad, Iran - Department of Medical Genetics, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran - Université de Lorraine, Unité de Recherche “Interactions Gène-Environnement en Physiopathologie Cardio Vasculaire” l’UMR INSERM U 1122, IGE-PCV, Nancy, France. Narges Zhiyan-abed 10031947532846005988 10031947532846005988 No Pardis Clinical and Genetics Laboratory, Mashhad, Iran - Razavi’s Social Welfare Organization, Mashhad, Iran. Mojila Nasseri 10031947532846005989 10031947532846005989 No Pardis Clinical and Genetics Laboratory, Mashhad, Iran. Mohammad Reza Abbaszadegan abbaszadeganmr@mums.ac.ir 10031947532846005990 10031947532846005990 Yes Pardis Clinical and Genetics Laboratory, Mashhad, Iran - Division of Human Genetics, Immunology Research Center, Avicenna Research Institute, MUMS, Mashhad, Iran.